CHK2_MOUSE - dbPTM
CHK2_MOUSE - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CHK2_MOUSE
UniProt AC Q9Z265
Protein Name Serine/threonine-protein kinase Chk2
Gene Name Chek2
Organism Mus musculus (Mouse).
Sequence Length 546
Subcellular Localization Nucleus, PML body. Nucleus, nucleoplasm. Recruited into PML bodies together with TP53..
Protein Description Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest, activation of DNA repair and apoptosis in response to the presence of DNA double-strand breaks. May also negatively regulate cell cycle progression during unperturbed cell cycles. Following activation, phosphorylates numerous effectors preferentially at the consensus sequence [L-X-R-X-X-S/T]. Regulates cell cycle checkpoint arrest through phosphorylation of CDC25A, CDC25B and CDC25C, inhibiting their activity. Inhibition of CDC25 phosphatase activity leads to increased inhibitory tyrosine phosphorylation of CDK-cyclin complexes and blocks cell cycle progression. May also phosphorylate NEK6 which is involved in G2/M cell cycle arrest. Regulates DNA repair through phosphorylation of BRCA2, enhancing the association of RAD51 with chromatin which promotes DNA repair by homologous recombination. Also stimulates the transcription of genes involved in DNA repair (including BRCA2) through the phosphorylation and activation of the transcription factor FOXM1. Regulates apoptosis through the phosphorylation of p53/TP53, MDM4 and PML. Phosphorylation of p53/TP53 at 'Ser-20' by CHEK2 may alleviate inhibition by MDM2, leading to accumulation of active p53/TP53. Phosphorylation of MDM4 may also reduce degradation of p53/TP53. Also controls the transcription of pro-apoptotic genes through phosphorylation of the transcription factor E2F1. Tumor suppressor, it may also have a DNA damage-independent function in mitotic spindle assembly by phosphorylating BRCA1. Its absence may be a cause of the chromosomal instability observed in some cancer cells. Promotes the CCAR2-SIRT1 association and is required for CCAR2-mediated SIRT1 inhibition (By similarity)..
Protein Sequence MKSHHQSHSSTSSKAHDSASCSQSQGGFSQPQGTPSQLHELSQYQGSSSSSTGTVPSSSQSSHSSSGTLSSLETVSTQELCSIPEDQEPEEPGPAPWARLWALQDGFSNLDCVNDNYWFGRDKSCEYCFDGPLLRRTDKYRTYSKKHFRIFREMGPKNCYIVYIEDHSGNGTFVNTELIGKGKRCPLSNNSEIALSLCRNKVFVFFDLTVDDQSVYPKELRDEYIMSKTLGSGACGEVKMAFERKTCQKVAIKIISKRRFALGSSREADTAPSVETEIEILKKLNHPCIIKIKDVFDAEDYYIVLELMEGGELFDRVVGNKRLKEATCKLYFYQMLVAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGQSKILGETSLMRTLCGTPTYLAPEVLVSNGTAGYSRAVDCWSLGVILFICLSGYPPFSEHKTQVSLKDQITSGKYNFIPEVWTDVSEEALDLVKKLLVVDPKARLTTEEALNHPWLQDEYMKKKFQDLLVQEKNSVTLPVAPAQTSSQKRPLELEVEGMPSTKRLSVCGAVL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
68PhosphorylationSSHSSSGTLSSLETV
CCCCCCCCCCCCEEE
25.97-
71PhosphorylationSSSGTLSSLETVSTQ
CCCCCCCCCEEECHH
33.08-
77PhosphorylationSSLETVSTQELCSIP
CCCEEECHHHHHCCC
23.0220371347
82PhosphorylationVSTQELCSIPEDQEP
ECHHHHHCCCCCCCC
54.53-
264PhosphorylationKRRFALGSSREADTA
HCCCCCCCCCCCCCC
27.3726239621
265PhosphorylationRRFALGSSREADTAP
CCCCCCCCCCCCCCC
32.1326239621
270PhosphorylationGSSREADTAPSVETE
CCCCCCCCCCCHHHH
47.7323984901
382PhosphorylationQSKILGETSLMRTLC
CCCCCCCHHHHHHHC
25.9229472430
383PhosphorylationSKILGETSLMRTLCG
CCCCCCHHHHHHHCC
18.8322817900
387PhosphorylationGETSLMRTLCGTPTY
CCHHHHHHHCCCCCE
16.66-
391PhosphorylationLMRTLCGTPTYLAPE
HHHHHCCCCCEECCE
16.09-
393PhosphorylationRTLCGTPTYLAPEVL
HHHCCCCCEECCEEE
30.8824759943
460PhosphorylationPEVWTDVSEEALDLV
CCHHCCCCHHHHHHH
32.31-
540PhosphorylationMPSTKRLSVCGAVL-
CCCCCEEEECEECC-
21.2822817900

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
68TPhosphorylationKinaseMAP3K20Q9ESL4
Uniprot
71SPhosphorylationKinasePLK3Q60806
Uniprot
77TPhosphorylationKinaseATMQ62388
Uniprot
77TPhosphorylationKinaseMAP3K20Q9ESL4
Uniprot
82SPhosphorylationKinasePLK3Q60806
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
77TPhosphorylation

-
77TPhosphorylation

-
82SPhosphorylation

-
383SPhosphorylation

-
387TPhosphorylation

-
391TPhosphorylation

-
460SPhosphorylation

-

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CHK2_MOUSE !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
BRD8_HUMANBRD8physical
20360068
CHK2_HUMANCHEK2physical
20360068
STK38_HUMANSTK38physical
20360068
JPH1_HUMANJPH1physical
20360068

Drug and Disease Associations
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CHK2_MOUSE

loading...

Related Literatures of Post-Translational Modification

TOP